Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-03-11

Clinical Trial Update: Adjuvant Intraperitoneal Floxuridine Added to Chemoradiation for Fully Resected Advanced Stomach Cancer [Phase 2]

View source ↗

Summary

This Phase 2 trial evaluated adding adjuvant intraperitoneal floxuridine to chemoradiation after complete resection in advanced gastric cancer; the study has co…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Floxuridine (FUDR) (floxuridine)

Snippet

Sponsor: NYU Langone Health | Conditions: Gastric Cancer, Stomach Cancer | Phase 2 | Status: COMPLETED